Status:
COMPLETED
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor compared to placebo in patients with type 2 diabetes. The anticipated time on study treatment is \< 3 months and the ta...
Eligibility Criteria
Inclusion
- adult patients 18-75 years of age;
- type 2 diabetes diagnosed \>=1 month before screening;
- no previous treatment, or previous treatment with no more than 2 oral medications.
Exclusion
- type 1 diabetes;
- type 2 diabetes treated with insulin or a PPAR gamma agonist during the 3 months before screening;
- patients who are pregnant, breastfeeding or not using a reliable contraceptive method.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
291 Patients enrolled
Trial Details
Trial ID
NCT00111670
Start Date
June 1 2005
End Date
July 1 2006
Last Update
November 2 2016
Active Locations (40)
Enter a location and click search to find clinical trials sorted by distance.
1
Salinas, California, United States, 93901
2
Clearwater, Florida, United States, 33765
3
Hialeah, Florida, United States, 33013
4
Pembroke Pines, Florida, United States, 33029